Shuai Li

Shuai Li joined Biohaven in November 2017 as Manager in Business Development and Corporate Strategy. Shuai comes to us from IBM, where she worked as Managing Strategy Consultant and performed data analytics to address real time business challenges. Previously, she worked part-time at several healthcare investment advising groups including Beacon VP and conducted extensive market and scientific due diligence on early stage biotechs. Shuai has passed CFA Level III and holds a Ph.D. from Harvard University, where she focused on cutting-edge small molecule drug development at Harvard Medical School. Prior to that, Shuai received her dual BSc in Chemistry & Biology and Economics from Tsinghua University.